Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of Xiaoer Fufang Moshizi Ointment in pediatric eczema (water sores)
CTR20250342Phase 2Active
- Sponsor
- Xinqikang Pharmaceutical
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of xiaoer fufang moshizi ruangao in atopic dermatitis (AD), sponsored by Xinqikang Pharmaceutical. Started Jun 2025; status: active.
02
Drugs
xiaoer fufang moshizi ruangao
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20250342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250342.